The development of a financial toxicity patient-reported outcome in cancer: The COST measure

Washington State Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis

(2013) Scott Ramsey et al.   HEALTH AFFAIRS

Cancer Patients’ Trade-offs Among Efficacy, Toxicity, and Out-of-Pocket Cost in the Curative and Noncurative Setting

(2013) Yu-Ning Wong et al.   MEDICAL CARE

Toward Patient-Centered Drug Development in Oncology

(2013) Ethan Basch   NEW ENGLAND JOURNAL OF MEDICINE

Full Disclosure — Out-of-Pocket Costs as Side Effects

(2013) Peter A. Ubel et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience

(2013) S. Y. Zafar et al.   ONCOLOGIST

Cost Concerns of Patients With Cancer

(2013) Tammy K. Stump et al.   Journal of Oncology Practice

Recommendations for Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research in Adult Oncology

(2012) Ethan Basch et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk Factors for Financial Hardship in Patients Receiving Adjuvant Chemotherapy for Colon Cancer: A Population-Based Exploratory Analysis

(2012) Veena Shankaran et al.   JOURNAL OF CLINICAL ONCOLOGY

US Mortality Rates for Oral Cavity and Pharyngeal Cancer by Educational Attainment

(2011) Amy Y. Chen   ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY

Association Between Prescription Co-Payment Amount and Compliance With Adjuvant Hormonal Therapy in Women With Early-Stage Breast Cancer

(2011) Alfred I. Neugut et al.   JOURNAL OF CLINICAL ONCOLOGY

Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2—Assessing Respondent Understanding

(2011) Donald L. Patrick et al.   VALUE IN HEALTH

Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 1—Eliciting Concepts for a New PRO Instrument

(2011) Donald L. Patrick et al.   VALUE IN HEALTH

Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): Searching for Standards

(2010) Charles S. Cleeland et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Medical Bankruptcy in the United States, 2007: Results of a National Study

(2009) David U. Himmelstein et al.   AMERICAN JOURNAL OF MEDICINE

Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis

(2009) Wilbert B. Van den Hout et al.   ARTHRITIS AND RHEUMATISM

Financial Burden Of Health Care, 2001–2004

(2008) Jessica S. Banthin et al.   HEALTH AFFAIRS

Deficiencies in current evaluations of the cost-effectiveness of biologic agents for RA

(2008) Wilbert B van den Hout   Nature clinical practice. Rheumatology